Equilibre Biopharmaceuticals B.V.
- Address
- Herengracht 540
Sponsor Overview
Specializations
Epilepsy and Focal Seizures
Research activity is centered on epilepsy, with emphasis on focal onset seizures in people receiving ongoing anti-seizure medication. The sponsor’s clinical interest lies in adjunctive therapy for seizure control and symptom management.
- Seizure disorders
- Focal onset seizures
- Adjunctive anti-seizure treatment
The sponsor is active across multiple research sites in Europe and other countries, with clinical work focused on treatment options for individuals whose seizures persist despite standard medication.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| A Randomized Phase 2 Study of Adjunctive EQU-001 for Uncontrolled Focal Onset Seizures |  Czechia France Italy Lithuania Poland Spain The Netherlands | Not Recruiting |
Data & Insights
This sponsor works with 1 molecule, of which 0 are not being studied by other sponsors.
This sponsor has worked with 27 sites across their trial portfolio.
Therapeutic Focus
- 1.Nervous System Diseases1 trial449 other sponsors
Partnered Research Centres
27 centres- Address
- Viale Gaetano Pieraccini 24, 50139 Florence
- Address
- 27 Rue Delbecque, 62660 Beuvry
- Address
- Rue Michel Polonovski, 59037 Lille
- Address
- Ul. Tadeusza Szafrana 5d / U2-U5, 30-363 Krakow
- Address
- Rue Du Morvan, 54500 Vandoeuvre Les Nancy
- Address
- Ul. Cicha 4/1, 20-078 Lublin
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Equilibre Biopharmaceuticals B.V..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.